GleamWall
中文EN

CTTH CTT PHARMACEUTICAL HOLDINGS, INC.

Pharmaceutical Preparations · OTC · SEC CIK 1035422 · Fiscal year ends 12/31

Financial factors as of 2015-09-30 (2015Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-1,345.6%
TTM EPS YoY-500.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-207.0%
ROA-146.3%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets20.0%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.17x
Accruals ratio-121.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20142014-12-31FY20132013-12-31
Income statement
Revenue——
SG&A expense$17,641$3,844
Operating income-$672,162-$18,911
Net income-$672,162-$18,911
EPS (basic)-0.04-0.01
EPS (diluted)-0.04-0.01
Weighted avg. shares (diluted)16.34M14.92M
Balance sheet
Cash & equivalents$81,179$0
Short-term investments—$0
Receivables$5,430$0
Current assets$1.05M$6,252
Total assets$1.66M$0
Current liabilities—$249,378
Total liabilities$169,490$29,322
Shareholders' equity$1.49M-$29,322
Shares outstanding19.51M14.92M
Cash flow statement
Operating cash flow-$72,250-$209
Investing cash flow$151,891$124,961
Financing cash flow—$0
Stock-based compensation$308,439$0

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.